201 related articles for article (PubMed ID: 24294944)
1. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus.
Su LC; Chen YH; Chen MC
ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944
[TBL] [Abstract][Full Text] [Related]
2. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus.
Chen MC; Liang HF; Chiu YL; Chang Y; Wei HJ; Sung HW
J Control Release; 2005 Nov; 108(1):178-89. PubMed ID: 16162366
[TBL] [Abstract][Full Text] [Related]
3. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
[TBL] [Abstract][Full Text] [Related]
5. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
[TBL] [Abstract][Full Text] [Related]
6. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
Bedair TM; Kang SN; Joung YK; Han DK
J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
[TBL] [Abstract][Full Text] [Related]
7. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents.
Chen MC; Chang Y; Liu CT; Lai WY; Peng SF; Hung YW; Tsai HW; Sung HW
Biomaterials; 2009 Jan; 30(1):79-88. PubMed ID: 18838155
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating.
Kim SM; Park KS; Lih E; Hong YJ; Kang JH; Kim IH; Jeong MH; Joung YK; Han DK
Acta Biomater; 2016 Jul; 38():143-52. PubMed ID: 27109766
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus coating on heparinized stents prevents restenosis and thrombosis.
Bae IH; Lim KS; Park DS; Shim JW; Lee SY; Jang EJ; Park JK; Kim JH; Jeong MH
J Biomater Appl; 2017 May; 31(10):1337-1345. PubMed ID: 28436251
[TBL] [Abstract][Full Text] [Related]
11. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
[TBL] [Abstract][Full Text] [Related]
12. Hemocompatibility and anti-fouling behavior of multilayer biopolymers immobilized on gold-thiolized drug-eluting cardiovascular stents.
Huang LY; Yang MC; Tsou HM; Liu TY
Colloids Surf B Biointerfaces; 2019 Jan; 173():470-477. PubMed ID: 30326363
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents.
Pan ChJ; Tang JJ; Weng YJ; Wang J; Huang N
J Control Release; 2006 Nov; 116(1):42-9. PubMed ID: 17046093
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
[TBL] [Abstract][Full Text] [Related]
15. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
[TBL] [Abstract][Full Text] [Related]
16. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
[TBL] [Abstract][Full Text] [Related]
17. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
[TBL] [Abstract][Full Text] [Related]
18. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
19. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.
Lemos PA; Farooq V; Takimura CK; Gutierrez PS; Virmani R; Kolodgie F; Christians U; Kharlamov A; Doshi M; Sojitra P; van Beusekom HM; Serruys PW
EuroIntervention; 2013 May; 9(1):148-56. PubMed ID: 23685303
[TBL] [Abstract][Full Text] [Related]
20. The Supralimus sirolimus-eluting stent.
Lemos PA; Bienert I
Expert Rev Med Devices; 2013 May; 10(3):295-300. PubMed ID: 23597097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
